Actively Recruiting
Pancreatic Cancer Screening in a Population at High Risk
Led by Masaryk Memorial Cancer Institute · Updated on 2026-04-21
700
Participants Needed
1
Research Sites
312 weeks
Total Duration
On this page
Sponsors
M
Masaryk Memorial Cancer Institute
Lead Sponsor
M
Masaryk University
Collaborating Sponsor
AI-Summary
What this Trial Is About
Pancreatic cancer is one of the diseases with the worst prognosis, which is mainly due to the initial asymptomatic prognosis. Unfortunately, the incidence of this disease in the Czech Republic is still increasing. In a certain proportion of patients, it is possible to predict the disease, e.g. due to family burdens. Regular follow-up of such individuals is the subject of the SCREPAN study: "Pancreatic Cancer Screening in High-Risk Persons".
CONDITIONS
Official Title
Pancreatic Cancer Screening in a Population at High Risk
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Willing to participate in the study
- Age 18 years or older
- For Arm A: chronic pancreatic disease related to cystic fibrosis or chronic pancreatitis and age 50 years or older
- For Arm B1: confirmed Peutz-Jeghers syndrome or familial melanoma syndrome or hereditary pancreatitis with specific age criteria or timing after first attack
- For Arm B2: confirmed diagnosis of hereditary syndromes (Lynch, HBOC, familial adenomatous polyposis, Li-Fraumeni) with at least one relative diagnosed with pancreatic ductal adenocarcinoma and age 50 or older or 10 years before youngest relative's diagnosis
- For Arm C: positive family history of pancreatic ductal adenocarcinoma without hereditary syndrome, age 50 or older or 10 years before youngest affected relative
You will not qualify if you...
- Unable to undergo radical curative surgery for pancreatic tumor
- Unable to undergo scheduled imaging examinations
- Having incurable malignant cancer
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Masaryk Memorial Cancer Institute
Brno, Czechia, 65653
Actively Recruiting
Research Team
M
Martina Lojova, Ph.D.
CONTACT
D
Dita Kozakova, Ing.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
SCREENING
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here